You are looking for

By embedding compliance at the core of decision-making, medtech and life science companies will be ready to rise to future challenges When we think about the key trends shaping the healthcare sector, it quickly becomes clear that ethics and compliance have a central role to play in the future of our industry. Consider the risks […]

The EU medical technology regulations need a rethink to boost competitiveness that better safeguards patient access to innovation  Europe has a strong and diverse medical technology sector and some of the best health services in the world. However, a serious crisis is on the horizon, which threatens our shared progress. We must address this challenge […]

With new global challenges on the horizon, compliance with the MedTech Europe Code is an investment in the future  If my years as a legal and compliance professional in Europe’s medical technology sector have taught me anything, it is the value of trust. It is vital that healthcare professionals and patients trust us to produce […]

MedTech Europe Manifesto: The EU has a key role in preparing for future challenges, from AMR and climate to global trade distortions and supply chain disruption  European health systems have faced severe stress tests in recent years, revealing some of the strengths and weaknesses of our services and institutions. Learning from this experience will be […]

The European Health Data Space (EHDS) regulation proposes a framework that would allow for the secure and efficient use of health data for research, innovation, policy-making, and regulatory activities. This type of framework for the ‘secondary use’ of health data has the potential to deliver new and meaningful insights that inform research and innovation, ultimately […]

In my experience as a nuclear medicine physician in a large hospital, Artificial Intelligence (AI) will help with the routine, time-consuming procedures of healthcare professionals. It can delineate tumours in the case of repetitive imaging and pre-digest work performed on earlier imaging. In these cases, I do not have to redo what has already been […]

The new Innovative Health Initiative (IHI) has prompted companies in the medical technology industry to think about taking part in more EU projects. For some, this is a new opportunity to build on existing experience. For others, it’s a new venture. With the right preparation, there are real benefits on offer thanks to this exciting […]

At the MedTech Forum that took place in Barcelona earlier this year, I joined a J&J MedTech sponsored panel entitled Data Governance in a Patient Pathway. I was on stage with peers from the industry, all looking at the topic from a different perspective, from the patient, to the healthcare provider, the policy maker to […]

The past few years have seen a seismic shift in the entire healthcare landscape. The COVID-19 crisis required a new level of “always-on” and “right now” innovation to enable care to be delivered to the front lines, to all patients, and across geographies. As COVID-19 evolves from an acute crisis to a chronic issue with unpredictable ebbs and flows, the hyper-focused approach to innovation is more important than ever. The world now knows what we can do, even when conditions are less than optimal. Our focus on helping patients by getting the best evidence, tools, and support to clinicians demonstrated the power of collaboration, imagination and dedication. Moving forward, patients and healthcare partners will accept nothing less than that level of commitment to transform the future of health forever.